CRISPR: patent battles from the US to Europe

24-04-2017

Catherine Coombes

CRISPR: patent battles from the US to Europe

EOPLEIMAGES / ISTOCK PHOTO

Patent bodies in the US and Europe have issued important decisions in patent battles over the gene-editing technology CRISPR, as Catherine Coombes of HGF reports.


patent, CRISPR, gene-editing, EPO, European Patent Office, HGF. Catherine Coombes, PAM sequence, DNA, CRISPR/Cas, EPO, Patent Trial and Appeal Board,

WIPR